Parkinson’s and dopamine. This image shows dopamine production in the substantia nigra of the midbrain and its role in movement regulation. In this representation, the substantia nigra, midbrain, basal ganglia, dopaminergic neurons, and cerebral cortex are identified. These structures enable motor control and cognitive integration.
Parkinson’s and dopamine have an altered function in the nervous system. Moreover, dopamine normally regulates voluntary movement. Additionally, it plays a role in mood and motivation. Furthermore, it is essential for overall functional balance.
On the other hand, in Parkinson’s disease, dopaminergic neurons degenerate. These neurons are located in the substantia nigra of the midbrain. Moreover, their loss reduces dopamine production. Additionally, neuronal communication is disrupted.
Transport of nerve signals occurs through neurotransmitters such as dopamine. For example, dopamine enables transmission in the basal ganglia. Moreover, when its levels decrease, motor control is impaired. Additionally, movements become slow and rigid.
Key processes include neuronal loss and dopamine deficiency. Moreover, symptoms such as tremors appear. However, movement disorders are also present. Additionally, non-motor symptoms such as cognitive decline may occur.
Regulation depends on dopaminergic neuron activity. Moreover, genetic factors may influence it. Additionally, aging increases disease risk. Furthermore, progression is gradual.
As a result, motor coordination progressively deteriorates. Additionally, balance may be affected. Moreover, quality of life declines.
Therefore, Parkinson’s disease and dopamine are essential to understand this disease. In conclusion, dopamine deficiency affects movement and key cognitive functions.